Jianfeng Tan Selected Research

Jianfeng Tan Research Topics

4	Neoplasms (Cancer) 01/2023 - 02/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2017
2	Lung Neoplasms (Lung Cancer) 03/2021 - 02/2021
1	Virus Diseases (Viral Diseases) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Adenocarcinoma of Lung 01/2023
1	Carcinoma (Carcinomatosis) 10/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2022
1	Necrosis 02/2021
1	Chronic Disease (Chronic Diseases) 08/2014

1	Tyrosine Kinase InhibitorsIBA 05/2024
1	ErbB Receptors (EGF Receptor)IBA 05/2024
1	Antiviral Agents (Antivirals)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	CrizotinibIBA 10/2022
1	osimertinibIBA 08/2022
1	Gefitinib (Iressa)FDA Link 08/2022
1	AfatinibIBA 08/2022
1	Caspase 1 (ICE Protease)IBA 08/2022
1	Sincalide FDA Link 03/2021
1	AntigensIBA 02/2021
1	VaccinesIBA 02/2021
1	Hematoxylin (Haematoxylon)IBA 02/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2021
1	Histocompatibility Antigens Class IIIBA 02/2021
1	Interleukin-6 (Interleukin 6)IBA 02/2021
1	CytokinesIBA 02/2021
1	Combined VaccinesIBA 02/2021
1	Interleukin-12 (IL 12)IBA 02/2021
1	Indicators and Reagents (Reagents)IBA 08/2014